BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schloer S, Goretzko J, Rescher U. Repurposing Antifungals for Host-Directed Antiviral Therapy? Pharmaceuticals 2022;15:212. [DOI: 10.3390/ph15020212] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Shen S, Zhang Y, Yin Z, Zhu Q, Zhang J, Wang T, Fang Y, Wu X, Bai Y, Dai S, Liu X, Jin J, Tang S, Liu J, Wang M, Guo Y, Deng F. Antiviral activity and mechanism of the antifungal drug, anidulafungin, suggesting its potential to promote treatment of viral diseases. BMC Med 2022;20:359. [PMID: 36266654 DOI: 10.1186/s12916-022-02558-z] [Reference Citation Analysis]
2 Schloer S, Treuherz D, Faist A, Witt M, Wunderlich K, Wiewrodt R, Wiebe K, Barth P, Wälzlein JH, Kummer S, Balkema-Buschmann A, Ludwig S, Brunotte L, Rescher U. 3D ex vivo tissue platforms to investigate the early phases of influenza A virus- and SARS-CoV-2-induced respiratory diseases. Emerg Microbes Infect 2022;:1-30. [PMID: 36000328 DOI: 10.1080/22221751.2022.2117101] [Reference Citation Analysis]
3 Kim JH, Cheng LW, Land KM. Advances in Antifungal Development: Discovery of New Drugs and Drug Repurposing. Pharmaceuticals 2022;15:787. [DOI: 10.3390/ph15070787] [Reference Citation Analysis]